Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,350) with videos related to
Page
of 135
Sort By:
Drug Development Research
|
April 22, 2020
A comprehensive review of computational techniques for the prediction of drug side effects
Kanica Sachdev, Manoj K Gupta
Drug Development Research
|
April 28, 2020
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2
Soltan A Ebrahimi
Drug Development Research
|
September 15, 2021
Fraxetin exerts anticancer effect in glioma by suppressing MiR-21-3p
Hanxun Yao, Xiaobin Li, Xuyan Pan, et al.
Drug Development Research
|
August 25, 2025
Targeting the Enzymatic Site of Botulinum Neurotoxin Type E With 8-Hydroxyquinolinol-Based Inhibitors: In Silico, In Vitro, and In Vivo Evaluation
Priyanka Sonkar, Vinita Chauhan Kushwah, Surabhi Agnihotri, et al.
Drug Development Research
|
June 17, 2015
Analgesic and anti-inflammatory activities of the ethanol extract of Taxillus tsaii Chiu in mice
Chia-Yu Liu, Yung-Jia Chiu, Chao-Lin Kuo, et al.
Drug Development Research
|
June 18, 2015
The Role of miR-21 in Cancer
Susan R Pfeffer, Chuan He Yang, Lawrence M Pfeffer
Drug Development Research
|
September 4, 2025
Targeted Inhibition of NOTCH2 and Importin-β Promotes Osteogenic Differentiation of Osteosarcoma Cells
Zhiyuan Wei, Yan Chen, Guoshi Liu, et al.
Drug Development Research
|
August 4, 2021
ORY-1001, a KDM1A inhibitor, inhibits proliferation, and promotes apoptosis of triple negative breast cancer cells by inactivating androgen receptor
Tian Wang, Fulin Zhang, Fulan Sun
Drug Development Research
|
May 29, 2020
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients
Elisabetta Maffioletti, Paolo Valsecchi, Alessandra Minelli, et al.
Drug Development Research
|
August 9, 2021
CircTHBS1 facilitates the progression of interstitial cystitis depending on the regulation of miR-139-5p/MFN2 axis
Chen Jiang, Ming Xu, Jin Zhu, et al.
Page
of 135
Search research articles
Search
Showing results (1031-1040 of 1,350) with videos related to
Sort By:
Page
of 135
Drug Development Research
|
April 22, 2020
A comprehensive review of computational techniques for the prediction of drug side effects
Kanica Sachdev, Manoj K Gupta
Drug Development Research
|
April 28, 2020
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2
Soltan A Ebrahimi
Drug Development Research
|
September 15, 2021
Fraxetin exerts anticancer effect in glioma by suppressing MiR-21-3p
Hanxun Yao, Xiaobin Li, Xuyan Pan, et al.
Drug Development Research
|
August 25, 2025
Targeting the Enzymatic Site of Botulinum Neurotoxin Type E With 8-Hydroxyquinolinol-Based Inhibitors: In Silico, In Vitro, and In Vivo Evaluation
Priyanka Sonkar, Vinita Chauhan Kushwah, Surabhi Agnihotri, et al.
Drug Development Research
|
June 17, 2015
Analgesic and anti-inflammatory activities of the ethanol extract of Taxillus tsaii Chiu in mice
Chia-Yu Liu, Yung-Jia Chiu, Chao-Lin Kuo, et al.
Drug Development Research
|
June 18, 2015
The Role of miR-21 in Cancer
Susan R Pfeffer, Chuan He Yang, Lawrence M Pfeffer
Drug Development Research
|
September 4, 2025
Targeted Inhibition of NOTCH2 and Importin-β Promotes Osteogenic Differentiation of Osteosarcoma Cells
Zhiyuan Wei, Yan Chen, Guoshi Liu, et al.
Drug Development Research
|
August 4, 2021
ORY-1001, a KDM1A inhibitor, inhibits proliferation, and promotes apoptosis of triple negative breast cancer cells by inactivating androgen receptor
Tian Wang, Fulin Zhang, Fulan Sun
Drug Development Research
|
May 29, 2020
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients
Elisabetta Maffioletti, Paolo Valsecchi, Alessandra Minelli, et al.
Drug Development Research
|
August 9, 2021
CircTHBS1 facilitates the progression of interstitial cystitis depending on the regulation of miR-139-5p/MFN2 axis
Chen Jiang, Ming Xu, Jin Zhu, et al.
Page
of 135